Product Profile of Anticancer Methotrexate B.P Injection
Serum Institute of India Ltd. supplies Anticancer Methotrexate B.P Injection. Serum Institute of India Ltd. manufactures measles and DTP group of vaccines. Anticancer Methotrexate B.P Injection inhibits the hydrogenetation of folic acid and prevents its participation in the synthesis of purines and nucleic acids. It also inhibits antibody synthesis. Anticancer Methotrexate B.P Injection has indications of acute lymphoblastic leukemia, choriocarcinoma. It may be used alone or in combination with other anticancer agents in the management of breast cancer, particularly squamous cell and small cell types, advanced stage non-hodgkin`s lymphoma, mycosis, fungoids, osterogenic sarcoma. This injection is also useful in treatment of psoriasis.
